Suitability of the use of benzodiazepines prescribed by the pharmacist in the elderly. A doctor-pharmacist collaboration study

To improve the use of benzodiazepines (BZD) in the elderly by a pharmacist-physician collaboration, and to insure that BZD are effective, safe, and used as long as necessary. A single blind controlled study was conducted on 11 pharmacies in the Community of Valencia. Eleven pharmacies in the Communi...

Full description

Saved in:
Bibliographic Details
Published in:Atención primaria 2012-07, Vol.44 (7), p.402
Main Authors: Velert Vila, Josefina, Velert Vila, M del Mar, Salar Ibáñez, Luis, Avellana Zaragoza, Juan Antonio, Moreno Royo, Lucrecia
Format: Article
Language:Spanish
Subjects:
Aged
Aged, 80 and over
Benzodiazepines - therapeutic use
Cooperative Behavior
Drug Prescriptions - standards
Humans
Interdisciplinary Communication
Pharmacists
Physicians
Single-Blind Method
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To improve the use of benzodiazepines (BZD) in the elderly by a pharmacist-physician collaboration, and to insure that BZD are effective, safe, and used as long as necessary. A single blind controlled study was conducted on 11 pharmacies in the Community of Valencia. Eleven pharmacies in the Community of Valencia. Patients older than 65 years treated with BZD attending the participating pharmacies. Interviews and pharmaceutical care for a year. detection of duplications, adverse drug reactions, drug interactions and measuring the effectiveness of the treatment. We studied 314 patients, randomised to control or intervention and who used 346 BZD. The majority (67%) of patients used BZD for more than 1 year. Only 5% patients with anxiety knew the duration of treatment should be one month. Long-acting BZD were used by 20% of the patients, 76% used medium-acting (39% lorazepam and 37% other BZD) and 4% short-acting BZD. A total of 132 drug interactions were detected and 278 adverse drug reactions: 32% memory loss, 21% drowsiness, 12% lack of coordination, 8.3% dizziness and confusion, 8,3% disorientation and 10% others. A total of 426 pharmacist interventions were performed, 30 accepted by the doctor and 78 were resolved at the end of the year of study. Eleven per cent of cases were considered satisfactory in the control group and 30% in the intervention group. The use of benzodiazepines in the Community of Valencia exceeds the recommendations of the Spanish Medicines Agency.
ISSN:1578-1275
DOI:10.1016/j.aprim.2011.07.018